{"count": 7, "results": [{"_id": "36522119", "pmid": 36522119, "title": "Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.", "journal": "J Pharmacol Sci", "authors": ["Marunouchi T", "Fujita K", "Takahashi K", "Namiki S", "Kyo L", "Uchida M", "Yano E", "Tanonaka K"], "date": "2023-01-01T00:00:00Z", "doi": "10.1016/j.jphs.2022.11.002", "meta_date_publication": "2023 Jan", "meta_volume": "151", "meta_issue": "1", "meta_pages": "17-27", "score": 50262.63, "text_hl": "These results suggest that @GENE_HSP90AA1 @GENE_299331 @@@Hsp90@@@ inhibition is partly responsible for the inhibitory effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on the development of @<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@myocardial remodeling@@@.", "citations": {"NLM": "Marunouchi T, Fujita K, Takahashi K, Namiki S, Kyo L, Uchida M, Yano E, Tanonaka K. Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure. J Pharmacol Sci. 2023 Jan;151(1):17-27. PMID: 36522119", "BibTeX": "@article{36522119, title={Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.}, author={Marunouchi T and Fujita K and Takahashi K and Namiki S and Kyo L and Uchida M and Yano E and Tanonaka K}, journal={J Pharmacol Sci}, volume={151}, number={1}, pages={17-27}}"}}, {"_id": "14985071", "pmid": 14985071, "title": "Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.", "journal": "Cardiovasc Res", "authors": ["Porter KE", "Turner NA", "O'Regan DJ", "Balmforth AJ", "Ball SG"], "date": "2004-03-01T00:00:00Z", "doi": "10.1016/j.cardiores.2003.11.032", "meta_date_publication": "2004 Mar 1", "meta_volume": "61", "meta_issue": "4", "meta_pages": "745-55", "score": 50063.402, "text_hl": "The purpose of this study was to investigate the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @SPECIES_9606 @@@human@@@ atrial myofibroblast proliferation. ", "citations": {"NLM": "Porter KE, Turner NA, O'Regan DJ, Balmforth AJ, Ball SG. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc Res. 2004 Mar 1;61(4):745-55. PMID: 14985071", "BibTeX": "@article{14985071, title={Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.}, author={Porter KE and Turner NA and O'Regan DJ and Balmforth AJ and Ball SG}, journal={Cardiovasc Res}, volume={61}, number={4}, pages={745-55}}"}}, {"_id": "15023931", "pmid": 15023931, "title": "Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts.", "journal": "Hypertension", "authors": ["Nadruz W Jr", "Lagosta VJ", "Moreno H Jr", "Coelho OR", "Franchini KG"], "date": "2004-05-01T00:00:00Z", "doi": "10.1161/01.HYP.0000124252.43470.2c", "meta_date_publication": "2004 May", "meta_volume": "43", "meta_issue": "5", "meta_pages": "1060-6", "score": 50060.125, "text_hl": "In conclusion, antioxidant properties of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ might play a role in @<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@myocardial remodeling@@@ induced by @DISEASE_Iron_Overload @DISEASE_MESH:D019190 @@@pressure overload@@@.", "citations": {"NLM": "Nadruz W Jr, Lagosta VJ, Moreno H Jr, Coelho OR, Franchini KG. Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts. Hypertension. 2004 May;43(5):1060-6. PMID: 15023931", "BibTeX": "@article{15023931, title={Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts.}, author={Nadruz W Jr and Lagosta VJ and Moreno H Jr and Coelho OR and Franchini KG}, journal={Hypertension}, volume={43}, number={5}, pages={1060-6}}"}}, {"_id": "21329846", "pmid": 21329846, "title": "Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations.", "journal": "J Am Coll Cardiol", "authors": ["Sicouri S", "Gianetti B", "Zygmunt AC", "Cordeiro JM", "Antzelevitch C"], "date": "2011-02-22T00:00:00Z", "doi": "10.1016/j.jacc.2010.08.649", "meta_date_publication": "2011 Feb 22", "meta_volume": "57", "meta_issue": "8", "meta_pages": "986-93", "score": 50060.0, "text_hl": "CONCLUSIONS: Our data suggest that in addition to its upstream actions to reduce @<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@atrial structural remodeling@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ exerts a direct antiarrhythmic effect by suppressing triggers responsible for the genesis of @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@.", "citations": {"NLM": "Sicouri S, Gianetti B, Zygmunt AC, Cordeiro JM, Antzelevitch C. Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. J Am Coll Cardiol. 2011 Feb 22;57(8):986-93. PMID: 21329846", "BibTeX": "@article{21329846, title={Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations.}, author={Sicouri S and Gianetti B and Zygmunt AC and Cordeiro JM and Antzelevitch C}, journal={J Am Coll Cardiol}, volume={57}, number={8}, pages={986-93}}"}}, {"_id": "15477401", "pmid": 15477401, "title": "Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.", "journal": "Circulation", "authors": ["Shiroshita-Takeshita A", "Schram G", "Lavoie J", "Nattel S"], "date": "2004-10-19T00:00:00Z", "doi": "10.1161/01.CIR.0000145163.56529.D1", "meta_date_publication": "2004 Oct 19", "meta_volume": "110", "meta_issue": "16", "meta_pages": "2313-9", "score": 50059.758, "text_hl": "METHODS AND RESULTS: We studied @SPECIES_9615 @@@dogs@@@ subjected to @<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@atrial tachypacing@@@ (@<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@ATP@@@) at 400 bpm in the absence and presence of treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Ascorbic_Acid @CHEMICAL_MESH:D001205 @@@vitamin C@@@, and combined vitamins C and E. ", "citations": {"NLM": "Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation. 2004 Oct 19;110(16):2313-9. PMID: 15477401", "BibTeX": "@article{15477401, title={Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.}, author={Shiroshita-Takeshita A and Schram G and Lavoie J and Nattel S}, journal={Circulation}, volume={110}, number={16}, pages={2313-9}}"}}, {"_id": "17270161", "pmid": 17270161, "title": "Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.", "journal": "Cardiovasc Res", "authors": ["Shiroshita-Takeshita A", "Brundel BJ", "Burstein B", "Leung TK", "Mitamura H", "Ogawa S", "Nattel S"], "date": "2007-04-01T00:00:00Z", "doi": "10.1016/j.cardiores.2007.01.002", "meta_date_publication": "2007 Apr 1", "meta_volume": "74", "meta_issue": "1", "meta_pages": "75-84", "score": 50057.66, "text_hl": "CONCLUSIONS: @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@CHF@@@-induced @<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@atrial structural remodeling@@@ and @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@AF@@@ promotion are attenuated by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, but not @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@. ", "citations": {"NLM": "Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S, Nattel S. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res. 2007 Apr 1;74(1):75-84. PMID: 17270161", "BibTeX": "@article{17270161, title={Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.}, author={Shiroshita-Takeshita A and Brundel BJ and Burstein B and Leung TK and Mitamura H and Ogawa S and Nattel S}, journal={Cardiovasc Res}, volume={74}, number={1}, pages={75-84}}"}}, {"_id": "27611832", "pmid": 27611832, "pmcid": "PMC5017578", "title": "The Role of the Rho/ROCK Pathway in Ang II and TGF-beta1-Induced Atrial Remodeling", "journal": "PLoS One", "authors": ["Liu LJ", "Yao FJ", "Lu GH", "Xu CG", "Xu Z", "Tang K", "Cheng YJ", "Gao XR", "Wu SH"], "date": "2016-09-09T00:00:00Z", "doi": "10.1371/journal.pone.0161625", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "9", "meta_pages": "e0161625", "score": 50041.633, "text_hl": "3.3 The effects of the elevated expression of the profibrotic factors on @<m>DISEASE_Atrial_Remodeling</m> @DISEASE_MESH:D064752 @@@atrial remodeling@@@", "citations": {"NLM": "Liu LJ, Yao FJ, Lu GH, Xu CG, Xu Z, Tang K, Cheng YJ, Gao XR, Wu SH. The Role of the Rho/ROCK Pathway in Ang II and TGF-beta1-Induced Atrial Remodeling PLoS One. 2016;11(9):e0161625. PMID: 27611832", "BibTeX": "@article{27611832, title={The Role of the Rho/ROCK Pathway in Ang II and TGF-beta1-Induced Atrial Remodeling}, author={Liu LJ and Yao FJ and Lu GH and Xu CG and Xu Z and Tang K and Cheng YJ and Gao XR and Wu SH}, journal={PLoS One}, volume={11}, number={9}, pages={e0161625}}"}}]}